“Serum Circulating Irisin Is A Promising Prognostic Biomarker Of Diabetes-Mediated Atherosclerotic Cardiovascular Disease”, Pjmcr, vol. 4, no. 4, pp. 870–883, Oct. 2025, doi: 10.64105/fj86jf73.